Profile: Novo Nordisk A/s is a healthcare company that focuses on the area of insulin delivery systems. We deal with haemostasis management, growth hormone therapy and hormone replacement therapy. We manufacture and market pharmaceutical products & services. Our NovoNorm® is a prandial glucose regulator, which is designed to restore the physiological mealtime insulin secretion. Our NovoSeven® is used for the treatment of spontaneous and surgical bleedings in haemophilia A & B patients with antibodies.